William Blair


William Blair Chimes in on Amazon.com, Inc. (AMZN) Following Comprehensive Pricing Survey

William Blair analyst Ryan Domyancic is out with a research report on Amazon.com, Inc.

William Blair Remains Bullish on Apple Inc. (AAPL) Following Samsung’s Acquisition of Harman

William Blair analyst Anil Doradla is offering insights on Apple Inc. (NASDAQ:AAPL) after arch-AAPL rival Samsung Electronics announced on Monday morning of its plans …

William Blair Slices the Price Target on Dynavax Technologies Corporation (DVAX) Following Second CRL for Heplisav

That was a rough week for investors in Dynavax Technologies Corporation (NASDAQ:DVAX), after the biotech firm announced on Monday, November 14th that it had received …

Third Quarter Breakdown: Why Analysts Are in Favor of Facebook Inc (FB) and Amazon.com, Inc. (AMZN)

Previewing Facebook Inc (NASDAQ:FB) and reviewing Amazon.com, Inc.

William Blair Raises Price Target on ARIAD Pharmaceuticals, Inc. (ARIA); Here’s Why

William Blair analyst Y Katherine Xu is out with a research report on shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) after having recently updated …

William Blair Positive on Gilead Sciences, Inc. (GILD) Following Data Releases

Last Thursday, Gilead Sciences, Inc. (NASDAQ:GILD) announced Phase III POLARIS topline data with sofosbuvir (nucleotide polymerase inhibitor)/velpatasvir (NS5A inhibitor)/voxilaprevir (protease inhibitor) in treatment-naïve …

William Blair Remains Confident on Apple Inc. (AAPL) Amid Alphabet Inc (GOOGL) Pixel Handset Launch; Sees No Threat to Shares

On Tuesday, Apple Inc. (NASDAQ:AAPL) tech rival Alphabet Inc (NASDAQ:GOOGL) announced its Android-based Pixel and Pixel XL phones launch, which will compete with …

William Blair Remains Positive on Cognizant Technology Solutions Corp (CTSH) Amid President Resignation and Internal Investigation

On Friday, Cognizant Technology Solutions Corp (NASDAQ:CTSH) announced that Rajeev Mehta has been appointed President of the Company, replacing Gordon Coburn who resigned. Additionally, an …

Analysts Weigh in on Two Collapsing Biotech Stocks: Threshold Pharmaceuticals, Inc. (THLD) and Alcobra Ltd (ADHD)

The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) and word from the FDA to …

William Blair Bullish on Sarepta Therapeutics Inc (SRPT) Amid First Patient Dosing in Phase III Trial and Catabasis Partnership

On Wednesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) announced that it has dosed the first patient in the Phase III ESEENCE trial for patients with …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts